The in vitro activities of N-fonnimidoyl thienamycin (MK0787) and nine other antibiotics were tested against 129 Colonies of isolates to be tested were picked from nutrient agar slants, suspended in 1 ml of MuellerHinton broth, and incubated overnight at 370C. Fifty microliters of a 1:1,000 dilution of this culture in Mueller-Hinton broth was added to each well of the microtiter plate, resulting in final inocula (determined by representative colony counts) of from 4.5 x 104 to 1.0 x 1O colony-forming units per ml. The concentrations of antimicrobial agents in these wells ranged from 0.12 to 100 ug/ml. The MIC was defined as the lowest 
N-fornimidoyl thienamycin (MK0787), a new beta-lactam derivative, has broad activity against gram-positive and gram-negative bacteria, including enterococci and strains of Staphylococcus epidermidis resistant to cephalosporins and other penicillinase-resistant penicillins (3, 4) . This observation led to the study of the comparative activities of N-formimidoyl thienamycin and 13 other antimicrobial agents in vitro against clinical isolates of the above microorganisms, Pseudomonas aeruginosa, and Serratia marcescens with the results recorded in this report.
MATERIALS AND METHODS
Microorganisms. The 129 isolates examined in this report were obtained from as many different patients at University Hospital, Birmingham, Alabama. These included 34 strains of S. epidernidis, 71 strains of enterococci, 7 strains of S. marcescens, and 17 strains of P. aeruginosa. All of the enterococci grew in 6.5% NaCl and were bile esculin positive. The seven S. marcescens isolates represented strains which were found in a previous study to be most resistant to aminoglycosides among 50 strains examined (2) . Table  1 shows the percentages of strains used in this study which exhibited minimal inhibitory concentrations (MICs) greater than levels usually achievable in serum (5 Colonies of isolates to be tested were picked from nutrient agar slants, suspended in 1 ml of MuellerHinton broth, and incubated overnight at 370C. Fifty microliters of a 1:1,000 dilution of this culture in Mueller-Hinton broth was added to each well of the microtiter plate, resulting in final inocula (determined by representative colony counts) of from 4.5 x 104 to 1.0 x 1O colony-forming units per ml. The concentrations of antimicrobial agents in these wells ranged from 0.12 to 100 ug/ml. The MIC was defined as the lowest Determinadon of MBCs. The minimal bactericidal concentrations (MBCs) of the isolates were determined by transferring 2 ,ul of the broth from each well exhibiting no visible growth onto a culture plate of Mueller-Hinton agar by using a replicator-type inoculator. The MBC was defined as the lowest concentration of antibiotic yielding two or fewer colonies after overnight incubation at 370C (the concentration at which at least 99.8% of the bacteria were rendered nonculturable). Since MBCs for all isolates tested were either equal to or no more than twofold greater than the MICs, detailed MBC data are not included.
RESULTS
The activities of N-formimidoyl thienamycin against 17 strains of P. aeruginosa were compared with those of tobramycin, gentamicin, amikacin, cefoperazone, cefotaxime, moxalactam, ticarcillin, and carbenicillin in vitro (Table  2) . Against this selected group of microorganisms, N-formimidoyl thienamycin was the most active beta-lactam agent. Fifty percent of the P. aeruginosa isolates were inhibited by 3.13 ,ug/ ml, and 90% were inhibited by 6.25 pg/rnl. In comparison, the next most active beta-lactam agent, cefoperazone, achieved 50 and 90% inhibition at concentrations of 12.5 and 64 gg/ml, respectively. Gentamicin and tobramycin were the most active of the aminoglycoside agents tested, with 50% inhibition at 0.5 ,Ag/ml each.
The activities of clindamycin, cephalothin, vancomycin, penicillin G, and methicillin were compared with those of N-formimnidoyl thienamycin against 34 strains of S. epidermnidis. NFormimidoyl thienamycin was the most active agent, with 50 and 90% of the strains being inhibited by 0.10 and 0.20 ,ug/ml, respectively. The next most active agent was clindamycin, with 90% inhibition by 1.56 ,ug/ml.
The activities of N-formimidoyl thienamycin against seven selected strains of S. marcescens were compared with those of moxalactam, amikacin, gentamicin, and tobramycin. N-Formimidoyl thienamycin demonstrated the most activity, with 90% inhibition at a concentration of 1.56 ,ug/ml. Moxalactam was the next most active agent, with 90% inhibition at a concentration of 12.5 jig/ml. Tobramycin was inactive at 100 ,ug/ml against all S. marcescens isolates.
The activities of N-formimidoyl thienamycin against 71 strains of Enterococcus sp. were compared with those of moxalactam and cefoperazone. N-Formimidoyl thienamycin was clearly the most active of the beta-lactam antibiotics tested. All strains were susceptible to 6.25 ug/ ml. Cefoperazone achieved 50 and 90% inhibition at 25 and 50 ,tg/ml, respectively. DISCUSSION Earlier studies demonstrated that thienamycin is a potent antibiotic with a broad spectrum of activity (6, 7) . N-Formimidoyl thienamycin, a derivative of thienamycin, has been shown to be more stable, more active in vitro, and more effective for treatment of infections in mice (H. Kropp Chemother. 11th and Intersci. Conf. Antimicrob. Agents Chemother. 19th, Boston, Mass., abstr. no. 231).
In the present study, with respect to the MIC required to inhibit growth of 90% of the isolates (MIC-90), N-formimidoyl thienamycin was more active than any antimicrobial agent tested. Comparison of the MIC-50 of each agent showed Nformimidoyl thienamycin to be more active than any other agent against S. epidermidis, S. marcescens, and enterococci, but against P. aeruginosa isolates it was less active than were amikacin, gentamicin, and tobramycin.
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